Delaying ADT for PSA-only prostate cancer relapse appears safe

ALEXANDRIA, VA. – Delaying the start of androgen-deprivation therapy may be a safe option for men with recurrent prostate cancer marked only by a rise in prostate-specific antigen, investigators...